Ittel T H, Griessner A, Sieberth H G
Department of Internal Medicine II, RWTH, Aachen, FRG.
Nephron. 1991;57(3):332-9. doi: 10.1159/000186284.
In previous investigations we found the gastrointestinal absorption of aluminum (Al) to be enhanced in uremic rats and this phenomenon could not be attributed to either calcitriol deficiency or secondary hyperparathyroidism. The purpose of this study was to examine whether carboxyl ligands such as lactate could affect the absorption of A1 in our model and, if so, whether this would impose additional alterations on the A1 absorption in uremia. Uremic rats and controls were studied with single oral loads of either A1 chloride or A1 lactate and, subsequently, urinary A1 excretion was measured for 5 days. Compared with Al chloride, administration of A1 lactate resulted in significantly higher urinary excretion rates of A1 in uremic rats (55.5 +/- 22.7 vs. 27.4 +/- 7.0 micrograms; 2.06 +/- 0.84 vs. 1.01 +/- 0.26 mumol) and in controls (23.6 +/- 8.5 vs. 11.9 +/- 4.3 micrograms; 0.87 +/- 0.31 vs. 0.44 +/- 0.16 mumol). However, with either A1 load the recovery of A1 from urine was substantially higher in uremic animals. In contrast, only in controls was there a more pronounced rise in serum A1 concentrations following ingestion of A1 lactate, whereas in uremic rats this increase had a similar magnitude following A1 chloride and A1 lactate, suggesting a larger apparent volume of distribution of the latter. Adjustment of the pH of the A1 lactate-containing solution to 7.0 or oral administration of sodium lactate together with A1 chloride yielded essentially similar results. These observations indicate that the enhanced intestinal absorption of A1 in uremia is further augmented by lactate regardless of the mixture of hydroxolactato complexes employed.(ABSTRACT TRUNCATED AT 250 WORDS)
在先前的研究中,我们发现尿毒症大鼠胃肠道对铝(Al)的吸收增强,且这种现象既不能归因于骨化三醇缺乏,也不能归因于继发性甲状旁腺功能亢进。本研究的目的是检验诸如乳酸等羧基配体是否会影响我们模型中铝的吸收,如果是,这是否会给尿毒症患者铝的吸收带来额外改变。对尿毒症大鼠和对照大鼠单次口服氯化铝或乳酸铝负荷,随后测量5天的尿铝排泄量。与氯化铝相比,给尿毒症大鼠施用乳酸铝导致尿铝排泄率显著更高(55.5±22.7对27.4±7.0微克;2.06±0.84对1.01±0.26微摩尔),对照大鼠也是如此(23.6±8.5对11.9±4.3微克;0.87±0.31对0.44±0.16微摩尔)。然而,无论哪种铝负荷,尿毒症动物尿中铝的回收率都显著更高。相反,仅在对照大鼠中,摄入乳酸铝后血清铝浓度有更明显的升高,而在尿毒症大鼠中,氯化铝和乳酸铝摄入后这种升高幅度相似,这表明后者的表观分布容积更大。将含乳酸铝溶液的pH值调至7.0或与氯化铝一起口服乳酸钠产生的结果基本相似。这些观察结果表明,无论所采用的羟基乳酸络合物混合物如何,乳酸都会进一步增强尿毒症患者肠道对铝的吸收。(摘要截断于250字)